Ashton Thomas Securities’s Thermo Fisher Scientific TMO Stock Holding History

Ashton Thomas Securities’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.84M	Sell	5,780 -175	-3%	-$95K	0.36%	68
2025 Q4	$3.46M	Buy	5,955 +334	+6%	+$189K	0.66%	35
2025 Q3	$2.73M	Buy	5,621 +3,722	+196%	+$1.73M	0.38%	63
2025 Q2	$770K	Buy	1,899 +23	+1%	+$9.62K	0.19%	130
2025 Q1	$939K	Buy	1,876 +30	+2%	+$16.2K	0.26%	101
2024 Q4	$966K	Buy	1,846 +29	+2%	+$15.9K	0.27%	92
2024 Q3	$1.12M	Buy	1,817 +862	+90%	+$510K	0.22%	102
2024 Q2	$508K	Buy	+955	New	+$547K	0.12%	160

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ashton Thomas Securities's TMO Position: Q1 2026 in Review

Ashton Thomas Securities reduced its Thermo Fisher Scientific (TMO) stake by 2.9% in Q1 2026, selling an estimated $95K and leaving 5,780 shares worth $2.84M. The position accounts for 0.36% of the portfolio, ranked #68.

Ashton Thomas Securities first reported a position in TMO in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.46M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Ashton Thomas Securities held 5,780 shares of Thermo Fisher Scientific worth $2.84M as of Q1 2026.
Ashton Thomas Securities sold 175 Thermo Fisher Scientific shares in Q1 2026, an estimated $95K.
Thermo Fisher Scientific made up 0.36% of Ashton Thomas Securities's portfolio in Q1 2026, its #68 holding.
Ashton Thomas Securities first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 8 quarters since.
Ashton Thomas Securities's Thermo Fisher Scientific position peaked at $3.46M in Q4 2025.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Ashton Thomas Securities's 13F filing for Q1 2026, filed 18 May 2026.